Drugs & Targets Janssen Biotech Inc. submitted supplemental Biologics License Application for daratumumab (Darzalex) to FDA September 06, 2016Vol.42 No.32
Drugs & Targets Biolinerx Ltd. and MD Anderson Cancer Center signed collaboration agreement September 06, 2016Vol.42 No.32
Drugs & Targets Exact Sciences Corp. said the Centers for Medicare and Medicaid Services issued an updated Evidence of Coverage notice for Medicare Advantage plans September 06, 2016Vol.42 No.32
Drugs & TargetsFree Cellectar Biosciences Inc. receives second-phase of NCI SBIR award August 05, 2016Vol.42 No.31
Drugs & TargetsFree Advanced Accelerator Applications and NCI form clinical trial agreement August 05, 2016Vol.42 No.31
Drugs & TargetsFree FDA and CMS to undergo parallel review of FoundationOne genomic assay August 05, 2016Vol.42 No.31
Drugs & TargetsFree FDA Grants Breakthrough Therapy Designation to LEE011 in Metastatic Breast Cancer August 05, 2016Vol.42 No.31
Drugs & Targets Mylan and Biocon submit marketing application to EMA for biosimilar Pegfilgrastim July 29, 2016Vol.42 No.30
